These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36265991)

  • 1. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals.
    Labiner AJ; Aronson A; Lucas AL
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):929-942. PubMed ID: 36265991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
    Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
    Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
    Dudley B; Brand RE
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for pancreatic cancer in high-risk individuals.
    Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
    BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals.
    Overbeek KA; Cahen DL; Bruno MJ
    Fam Cancer; 2024 Aug; 23(3):279-293. PubMed ID: 38573399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer.
    Earl J; Fuentes R; Sanchez MEC; de Paredes AGG; Muñoz M; Sanjuanbenito A; Lobo E; Caminoa A; Rodríguez M; Barreto E; López JV; Ruz-Caracuel I; Durán SL; Olcina JRF; Sánchez BL; Páez SC; Torres A; Blázquez J; Sequeros EV; Carrato A
    Fam Cancer; 2024 Aug; 23(3):383-392. PubMed ID: 38753287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic cancer-screening or surveillance?].
    Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
    Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Cancer Surveillance in Carriers of a Germline
    Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
    J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
    Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
    AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
    Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
    Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
    [No Abstract]   [Full Text] [Related]  

  • 13. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Overbeek KA; Levink IJM; Koopmann BDM; Harinck F; Konings ICAW; Ausems MGEM; Wagner A; Fockens P; van Eijck CH; Groot Koerkamp B; Busch ORC; Besselink MG; Bastiaansen BAJ; van Driel LMJW; Erler NS; Vleggaar FP; Poley JW; Cahen DL; van Hooft JE; Bruno MJ;
    Gut; 2022 Jun; 71(6):1152-1160. PubMed ID: 33820756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective.
    Copur MS; Talmon GA; Wedel W; Hart JD; Merani S; Vargasi LM
    Oncology (Williston Park); 2020 Jun; 34(6):196-201. PubMed ID: 32609864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Pancreatic Ductal Adenocarcinoma.
    Diaz KE; Lucas AL
    Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress report: familial pancreatic cancer.
    Mintziras I; Bartsch DK
    Fam Cancer; 2019 Jul; 18(3):359-362. PubMed ID: 30796632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs.
    Huang C; Hecht EM; Soloff EV; Tiwari HA; Bhosale PR; Dasayam A; Galgano SJ; Kambadakone A; Kulkarni NM; Le O; Liau J; Luk L; Rosenthal MH; Sangster GP; Goenka AH
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431151. PubMed ID: 38809122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
    Del Chiaro M; Zerbi A; Capurso G; Zamboni G; Maisonneuve P; Presciuttini S; Arcidiacono PG; Calculli L; Falconi M;
    Dig Liver Dis; 2010 Sep; 42(9):597-605. PubMed ID: 20627831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.